Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px
Document › Details

Danaher Corporation. (9/10/15). "Press Release: Danaher Announces Pricing of Senior Notes Offering". Washington, DC.

Region Region United States (USA)
Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 Pall Corporation (Group)
  Today Danaher (Group)
  Group Danaher (Group)
Products Product investment banking
  Product 2 laboratory equipment and instruments
Index terms Index term Danaher–SEVERAL: credit, 201509–2018 public offering $500m senior notes 1.650% due 2018 at offering price of 99.866% of principal amount
  Index term 2 Pall Corp–Danaher: investment, 201505–201508 acqu merger $13.8b net of cash/debt in cash $127.2/share
Person Person Gugino, Matthew E. (Danaher 201407 VP Investor Relations)

Danaher Corporation (NYSE: DHR) announced today that it has priced a public offering of:

> $500 million principal amount of 1.650% senior notes due 2018 at an offering price of 99.866% of the principal amount;

> $500 million principal amount of 2.400% senior notes due 2020 at an offering price of 99.757% of the principal amount;

> $500 million principal amount of 3.350% senior notes due 2025 at an offering price of 99.857% of the principal amount; and

> $500 million principal amount of 4.375% senior notes due 2045 at an offering price of 99.784% of the principal amount.

Danaher expects to receive net proceeds, after deducting estimated expenses and the underwriters' discounts and commissions, of approximately $1.98 billion. Danaher anticipates using the net proceeds from the offering to repay a portion of the commercial paper issued to finance a portion of the purchase price for Danaher's recently closed acquisition of Pall Corporation. The offering is expected to close on September 15, 2015, subject to customary closing conditions.

Citigroup, Barclays, Jefferies, J.P. Morgan, MUFG and Wells Fargo Securities are acting as joint book-running managers for the offering.

The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission (the "SEC").

The offering of senior notes may be made only by means of a prospectus and prospectus supplement. Investors may obtain these documents for free by visiting EDGAR on the SEC website at Alternatively, copies of the prospectus and prospectus supplement relating to the securities can be obtained from Citigroup at 1-800-831-9146; and from Barclays at 1-888-603-5847.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, the senior notes or any other securities, nor shall there be any offer, solicitation or sale of any security mentioned in this press release in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world-class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. The Company's globally diverse team of 80,000 associates is united by a common culture and operating system, the Danaher Business System.


Statements in this release that are not strictly historical, including the statements regarding the closing of the offering, the anticipated use of proceeds and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including Danaher's 2014 Annual Report on Form 10-K and Danaher's Quarterly Report on Form 10-Q for the second quarter of 2015. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

For further information: Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860

Record changed: 2015-10-30


Picture EBD Group Biotech Showcase 2019 San Francisco BTS January 600x60px

More documents for Danaher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top